Shanghai Junshi Biosciences Co., Ltd. (688180.SS)
CNY 30.2
(0.77%)
CNY 30.2
(0.77%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.21 Billion CNY | -11.84% |
| 2022 | 3.64 Billion CNY | 8.48% |
| 2021 | 3.35 Billion CNY | 16.21% |
| 2020 | 2.89 Billion CNY | 95.48% |
| 2019 | 1.47 Billion CNY | 115.96% |
| 2018 | 684.79 Million CNY | 97.66% |
| 2017 | 346.44 Million CNY | 129.31% |
| 2016 | 151.08 Million CNY | 101.94% |
| 2015 | 74.81 Million CNY | 97.99% |
| 2014 | 37.78 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 699.99 Million CNY | 11.96% |
| 2024 Q2 | 625.22 Million CNY | 7.39% |
| 2024 Q1 | 582.18 Million CNY | -50.92% |
| 2023 Q1 | 783.47 Million CNY | -58.29% |
| 2023 FY | 3.21 Billion CNY | -11.84% |
| 2023 Q4 | 1.18 Billion CNY | 6940.94% |
| 2023 Q3 | -17.33 Million CNY | -102.52% |
| 2023 Q2 | 687.11 Million CNY | -12.3% |
| 2022 FY | 3.64 Billion CNY | 8.48% |
| 2022 Q4 | 1.87 Billion CNY | 1624.77% |
| 2022 Q3 | 108.91 Million CNY | -85.73% |
| 2022 Q1 | 794.93 Million CNY | -21.7% |
| 2022 Q2 | 763.02 Million CNY | -4.01% |
| 2021 FY | 3.35 Billion CNY | 16.21% |
| 2021 Q1 | 843.23 Million CNY | -12.16% |
| 2021 Q2 | 736.94 Million CNY | -12.6% |
| 2021 Q3 | 672.4 Million CNY | -8.76% |
| 2021 Q4 | 1.01 Billion CNY | 50.99% |
| 2020 Q1 | 380.38 Million CNY | -25.9% |
| 2020 Q3 | 841.39 Million CNY | 20.26% |
| 2020 FY | 2.89 Billion CNY | 95.48% |
| 2020 Q2 | 699.67 Million CNY | 83.94% |
| 2020 Q4 | 959.99 Million CNY | 14.1% |
| 2019 Q4 | 513.35 Million CNY | 43.58% |
| 2019 Q2 | 147.3 Million CNY | -66.87% |
| 2019 Q1 | 444.57 Million CNY | 54.4% |
| 2019 FY | 1.47 Billion CNY | 115.96% |
| 2019 Q3 | 357.55 Million CNY | 142.73% |
| 2018 Q3 | 157.31 Million CNY | -7.73% |
| 2018 FY | 684.79 Million CNY | 97.66% |
| 2018 Q2 | 170.49 Million CNY | 67.14% |
| 2018 Q1 | 102 Million CNY | 19.68% |
| 2018 Q4 | 287.93 Million CNY | 83.03% |
| 2017 Q1 | 82.21 Million CNY | 131.71% |
| 2017 FY | 346.44 Million CNY | 129.31% |
| 2017 Q4 | 85.23 Million CNY | 5.04% |
| 2017 Q3 | 81.13 Million CNY | 7.45% |
| 2017 Q2 | 75.51 Million CNY | -8.15% |
| 2016 Q4 | 35.48 Million CNY | -33.3% |
| 2016 FY | 151.08 Million CNY | 101.94% |
| 2016 Q3 | 53.19 Million CNY | 119.75% |
| 2016 Q2 | 24.2 Million CNY | -0.0% |
| 2016 Q1 | 24.2 Million CNY | -12.76% |
| 2015 Q2 | 9.66 Million CNY | -0.0% |
| 2015 Q3 | 27.74 Million CNY | 187.24% |
| 2015 FY | 74.81 Million CNY | 97.99% |
| 2015 Q1 | 9.66 Million CNY | -22.96% |
| 2015 Q4 | 27.74 Million CNY | 0.0% |
| 2014 Q2 | 6.35 Million CNY | -0.0% |
| 2014 Q4 | 12.53 Million CNY | 0.0% |
| 2014 FY | 37.78 Million CNY | 0.0% |
| 2014 Q3 | 12.53 Million CNY | 97.31% |
| 2014 Q1 | 6.35 Million CNY | 0.0% |